Pt. F. No.2-2/2014/CGHS HQ/PPT/CGHS (P)
Government of India
Ministry of Health & Family welfare
0/0 The Additional Director CGHS (HQ)
CGHS Building, Sector 12, R K Puram,
New Delhi 110022
Dated at New Delhi the 01.10.2014
OFFICE MEMORANDUM
With reference to the O.M. No. 2-2/2014/CGHS HQ/PPT/CGHS (P) of Ministry of Health and Family Welfare, Department of Health & Family Welfare, dated 25.8.2014, I have been directed to inform that the CGHS formulary is under revision. In the meantime, the formularies of the EX-Servicemen Contributory Health Scheme (ECHS) and Employee State Insurance Corporation (ESIC) have also been adopted to avoid hardship to the beneficiaries. These formularies are also placed on Website of the CGHS. It has been reported that still there are a few essential medicines which are not covered by any of these formularies. It is therefore clarified that till CGHS formulary is revised, CMO I/Cs may use their discretion to supply such medicines which they consider essential and are not in the formularies of CGHS, ESIC and ECHS subject to following:-
1. In such cases the duration of prescription should not be for more than seven days and the cost of the medicine must be less than Rs. 1500.00 per Week.
2. It should be approved by the Drug Controller General of India (DCGI), for use in India for that particular indication.
3. In case of imported drug, the drug can be prescribed only when the Indian substitute is not available and the drug is approved by DCGI for use in India for that particular indication.
4. In case, if the duration of treatment is more than one week and /or the cost is more than Rs. 1500.00, the prior permission of AD(MSD)/ AD of the City must be obtained.
This is issued with approval of the competent authority
sd/-
(Dr. Sharda Verma)
Director CG HS
Source: http://msotransparent.nic.in/writereaddata/cghsdata/linkimages/8348884849.pdf
Stay connected with us via Facebook, Google+ or Email Subscription.
Subscribe to Central Government Employee News & Tools by Email [Click Here]
Follow us: Twitter [click here] | Facebook [click here] | Google+ [click here]
Admin
COMMENTS